Insider · CIK 0001297000

Scots-Knight Denise

CIK 0001297000 Name as filed on the most recent filing

Filed as Scots-Knight Denise (2)· Pollard-Knight Denise (10)

20 transaction lines · from 12 filings · filed 2005-11-16 to 2024-09-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

20 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-09-13 S, Open-market sale Mereo BioPharma Group plcMREO 253,454, disposed Open Form 4 filing 0000950170-24-106976
2024-09-12 S, Open-market sale Mereo BioPharma Group plcMREO 127,968, disposed Open Form 4 filing 0000950170-24-106976
2024-06-26 S, Open-market sale Mereo BioPharma Group plcMREO 313,101, disposed Open Form 4 filing 0000950170-24-078465
2024-06-25 S, Open-market sale Mereo BioPharma Group plcMREO 150,386, disposed Open Form 4 filing 0000950170-24-078465
2014-12-31 S, Open-market sale OncoMed Pharmaceuticals IncOMED 82,300, disposed Open Form 4 filing 0001140361-15-000072
2014-12-30 S, Open-market sale OncoMed Pharmaceuticals IncOMED 119,286, disposed Open Form 4 filing 0001140361-14-046759
2014-12-29 S, Open-market sale OncoMed Pharmaceuticals IncOMED 214,048, disposed Open Form 4 filing 0001140361-14-046759
2014-12-26 S, Open-market sale OncoMed Pharmaceuticals IncOMED 47,516, disposed Open Form 4 filing 0001140361-14-046759
2014-12-19 S, Open-market sale OncoMed Pharmaceuticals IncOMED 448,310, disposed Open Form 4 filing 0001140361-14-046335
2014-12-10 S, Open-market sale OncoMed Pharmaceuticals IncOMED 172,889, disposed Open Form 4 filing 0001140361-14-044800
2014-12-09 S, Open-market sale OncoMed Pharmaceuticals IncOMED 506,970, disposed Open Form 4 filing 0001140361-14-044800
2014-12-08 S, Open-market sale OncoMed Pharmaceuticals IncOMED 37,435, disposed Open Form 4 filing 0001140361-14-044800
2014-12-05 S, Open-market sale OncoMed Pharmaceuticals IncOMED 2 lines 539,951, disposed Open Form 4 filing 0001140361-14-044349
2014-06-30 S, Open-market sale OncoMed Pharmaceuticals IncOMED 270,919, disposed Open Form 4 filing 0001140361-14-027378
2014-06-25 S, Open-market sale OncoMed Pharmaceuticals IncOMED 76,624, disposed Open Form 4 filing 0001140361-14-026846
2014-06-24 S, Open-market sale OncoMed Pharmaceuticals IncOMED 277,320, disposed Open Form 4 filing 0001140361-14-026658
2014-06-23 S, Open-market sale OncoMed Pharmaceuticals IncOMED 1,277,429, disposed Open Form 4 filing 0001140361-14-026658
2013-07-23 P, Open-market purchase OncoMed Pharmaceuticals IncOMED 1,000,008, acquired Open Form 4 filing 0001181431-13-041152
2005-11-14 S, Open-market sale Idenix Pharmaceuticals IncIDIX 12,973,954, disposed Open Form 4 filing 0000909518-05-000899

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 1
  • Open-market sale 19
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Scots-Knight Denise, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001297000

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.